Eli Lilly and Company
This role involves researching and developing lipid nanoparticle (LNP) formulations for preclinical delivery systems within a platform research team. The incumbent will characterize and evaluate formulations while maintaining laboratory safety standards and delivering technical support across R&D programs. Success requires hands-on technical expertise in formulation processes alongside strong analytical skills independent leadership in a cross-functional environment.
Headquarters
Indianapolis, Indiana, United States
Company Size
10001+ employees
Founded
1876
Eli Lilly and Company is a global biopharmaceutical company headquartered in Indianapolis, Indiana. It discovers, develops, manufactures and commercializes prescription medicines across therapeutic areas including diabetes, oncology, immunology, neuroscience and pain, and has a longstanding history in insulin and other major drug discoveries. Lilly invests heavily in research and clinical development and partners with biotech, academic institutions, and industry collaborators to advance biologics, small molecules, and precision medicines. The company operates global manufacturing and commercial networks and provides patient-support programs to improve access to its therapies.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Eli Lilly and Company.
89% above the average for this role
Li Auto OTA Upgrade And Charging Use Test Investor Patience
1 week ago
Contract SRA / Scientist, Lipid Nanoparticle (LNP) Discovery
Addition Therapeutics
Senior Research Associate, LNP Production
MiraiBio Group at Hitachi Solutions America
Senior Research Associate, LNP Production
Flagship Pioneering, Inc.
Formulation Scientist
GenScript
Research Associate II, CRISPR-X - LNP
CRISPR Therapeutics
Nanoparticle Formulation Scientist
GenScript